Question 1

What are the potential benefits of adding tocilizumab to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs clinical trial (NCT00996606). Contact the study team or your healthcare provider for specific answers.

Question 2

Are there any specific risks or side effects I should be aware of with this combination?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs clinical trial (NCT00996606). Contact the study team or your healthcare provider for specific answers.

Question 3

How will we monitor my progress during this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs clinical trial (NCT00996606). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I do if I experience any side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs clinical trial (NCT00996606). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs clinical trial (NCT00996606). Contact the study team or your healthcare provider for specific answers.

Question 6

What is the expected duration of treatment with tocilizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs clinical trial (NCT00996606). Contact the study team or your healthcare provider for specific answers.

What this study is about